| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025761 |
| Receipt No. | R000029583 |
| Official scientific title of the study | An exploratory study on the effect of functional food |
| Date of disclosure of the study information | 2017/01/26 |
| Last modified on | 2018/07/18 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | An exploratory study on the effect of functional food | |
| Title of the study (Brief title) | An exploratory study on the effect of functional food | |
| Region |
|
|
| Condition | |||
| Condition | Not applicable | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the effect of functional food containing beverage on blood glucose increase. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Efficacy : Area under the curve of blood glucose level.
Safety : Incidence of adverse effects |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Subjects take a bottle of placebo beverage once in a day. After 6-9 days washout, subjects take a bottle of one kind of functional food containing beverage once in a day. After 6-9 days washout, subjects take a bottle of two kinds of functional food containing beverage (low dose) once in a day. After 6-9 days washout, subjects take a bottle of two kinds of functional food containing beverage (high dose) once in a day. In each time, subjects take 75g of glucose 30mins after beverage intake. | |
| Interventions/Control_2 | Subjects take a bottle of one kind of functional food containing beverage once in a day. After 6-9 days washout, subjects take a bottle of two kinds of functional food containing beverage (low dose) once in a day. After 6-9 days washout, subjects take a bottle of two kinds of functional food containing beverage (high dose) once in a day. After 6-9 days washout, subjects take a bottle of placebo beverage once in a day. In each time, subjects take 75g of glucose 30mins after beverage intake. | |
| Interventions/Control_3 | Subjects take a bottle of two kinds of functional food containing beverage (low dose) once in a day. After 6-9 days washout, subjects take a bottle of two kinds of functional food containing beverage (high dose) once in a day. After 6-9 days washout, subjects take a bottle of placebo beverage once in a day. After 6-9 days washout, subjects take a bottle of one kind of functional food containing beverage once in a day. In each time, subjects take 75g of glucose 30mins after beverage intake. | |
| Interventions/Control_4 | Subjects take a bottle of two kinds of functional food containing beverage (high dose) once in a day. After 6-9 days washout, subjects take a bottle of placebo beverage once in a day. After 6-9 days washout, subjects take a bottle of one kind of functional food containing beverage once in a day. After 6-9 days washout, subjects take a bottle of two kinds of functional food containing beverage (low dose) once in a day. In each time, subjects take 75g of glucose 30mins after beverage intake. | |
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects whose past fasting blood glucose levels were between 100 mg/dL or more and less than 130 mg/dL are screened by 75 g OGTT and subjects who are diagnosed as borderline hyperglycemia or high normal blood glucose will be selected. | |||
| Key exclusion criteria | (1)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating.
(2)Subjects with disease on heart, liver, kidney or other organs complication. (3)Subjects with a previous history of disease on circulatory organs (4)Subjects who have allergic reaction to drug medicine and food. (5)Subjects who drink alcohol a lot and smoke a lot. (6)Subjects who have an extremely irregular dietary habit. (7)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the test results. (8)Subjects who are judged as unsuitable for the study by the principal investigator for other reasons. |
|||
| Target sample size | 28 | |||
| Research contact person | |
| Name of lead principal investigator | Norihito Murayama |
| Organization | Suntory Global Innovation Center Ltd. |
| Division name | Research Institute |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan |
| TEL | 050-3182-0588 |
| Norihito_Murayama@suntory.co.jp | |
| Public contact | |
| Name of contact person | Hiroshi Watanabe |
| Organization | Suntory Global Innovation Center Ltd. |
| Division name | Research Institute |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan |
| TEL | 050-3182-0593 |
| Homepage URL | |
| H_Watanabe@suntory.co.jp | |
| Sponsor | |
| Institute | Suntory Global Innovation Center Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Suntory Global Innovation Center Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029583 |